DSM Biologics aims for global leadership position among independent contract manufacturers for the pharmaceutical industry
ML51 Downstream Processing
ML31 Fermentor
The new fermentation unit consists of clean rooms and a fermentor train. The fermentor train consists of two seed fermentors of 50 and 320 litres for culturing cells and a 2,000-litre production fermentor. DSM Biologics amply meets the quality standards set by the pharmaceutical industry (cGMP). The DSM Biologics site in Montreal is jointly owned by DSM and Societé générale de financement du Québec (SGF).
Ambitions
The fact that the new unit was officially opened by DSM Managing Board chairman Peter Elverding underlined the importance of the role played by DSM Biologics' ambitions in DSM's transformation into a specialty company. The ceremony was also attended by representatives of the Province of Quebec, which supports the establishment and development of advanced biotechnological industries in the Montreal region.
Most read news
Organizations
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.